
Advos
Advos.io
@advos
26744 articles
Articles

Aegis Capital Corp. Completes $4.3 Million Public Offering for Stardust Power
Aegis Capital Corp. has announced the completion of a $4.3 million underwritten public offering for Stardust Power Inc. (NASDAQ: SDST), a developer of battery-grade lithium products. The offering consisted of 21,500,000 shares of common stock priced at $0.20 per share. Additionally, Aegis has been granted a 45-day option to...
June 18, 2025Read the full article

Telomir Pharmaceuticals Reports Preclinical Success for Telomir-1 in Progeria Cell Lines
Telomir Pharmaceuticals (NASDAQ: TELO) has unveiled promising preclinical results for its lead candidate, Telomir-1, demonstrating its efficacy in preventing cellular aging within human progeria cell lines. These findings, derived from studies conducted by Smart Assays, highlight Telomir-1's ability to improve cell viabilit...
June 18, 2025Read the full article

Telomir Pharmaceuticals Reports Preclinical Success for Telomir-1 in Progeria Cell Lines
Telomir Pharmaceuticals (NASDAQ: TELO) has announced significant preclinical success with its lead candidate, Telomir-1, in treating Hutchinson-Gilford Progeria Syndrome (HGPS), a rare pediatric aging disorder. The drug demonstrated the ability to prevent cellular aging in human progeria cell lines, improving cell viability...
June 18, 2025Read the full article

Food Is Medicine Programs Show Promise in Improving Health Outcomes, More Research Needed
The American Heart Association's recent systematic review of Food Is Medicine (FIM) programs reveals their potential to enhance diet quality and food security for individuals with or at high risk for chronic diseases. However, the review also identifies a need for more comprehensive research to fully understand the clinical...
June 18, 2025Read the full article

Quantum BioPharma Ltd. Advances in Brain and Alcohol Health with Phase 2 Trial Approval
Quantum BioPharma Ltd. (NASDAQ: QNTM) has recently achieved a pivotal milestone with the human ethics approval for a Phase 2 trial of FSD202, targeting patients with Idiopathic Mast Cell Activation Syndrome. This development underscores the company's dedication to tackling inflammatory pain, a area with significant unmet me...
June 18, 2025Read the full article

Psyence Biomedical Ltd. to Showcase at Psychedelic Science 2025
Psyence Biomedical Ltd. (NASDAQ: PBM), a leader in the development of nature-derived psychedelic medicines, has announced its participation in Psychedelic Science 2025. Mary-Elizabeth Gifford, the company's Chief of Global Impact, will speak on a panel titled 'We are the Guardrails: Profit with Purpose,' focusing on the int...
June 18, 2025Read the full article

PolyPid Secures $26.7 Million Funding, Advances Toward FDA Approval with Promising Phase 3 Data
PolyPid Ltd., a biotech firm specializing in surgical infection prevention, has announced a significant financial and clinical milestone with the securing of $26.7 million through warrant exercises. This development comes on the heels of successful Phase 3 trial results for its innovative D-PLEX₁₀₀ technology, which targets...
June 18, 2025Read the full article

SolarBank Corporation Embraces Bitcoin Treasury Strategy to Diversify Assets and Attract Investors
SolarBank Corporation, a leader in renewable and clean energy projects across Canada and the U.S., has taken a significant step by integrating bitcoin into its treasury reserves. This move not only diversifies the company's asset portfolio but also taps into the growing investor interest in cryptocurrency, blending the inno...
June 18, 2025Read the full article

Alvarez & Marsal Report Urges Retailers to Act Now on Tariff Impacts
The latest report from Alvarez & Marsal's Consumer and Retail Group, titled 'Tariffs & Turmoil – Never Let a Good Crisis Go To Waste', serves as a critical wake-up call for retailers. It emphasizes the urgent need for companies to proactively address the challenges posed by shifting global trade policies and economic pressu...
June 18, 2025Read the full article

LezDo TechMed Introduces AI-Powered Billing System for Medical Record Reviews
LezDo TechMed, a prominent name in the medical record review outsourcing sector, has unveiled CaseDrive, a groundbreaking billing system aimed at revolutionizing how clients manage payments for medical record review services. This innovation addresses common industry challenges such as hidden fees, unclear invoices, and pay...
June 18, 2025Read the full article

Intelligent Bio Solutions Inc. to Implement Fingerprint Drug Testing in Australian Waste Management Sector
Intelligent Bio Solutions Inc. (NASDAQ: INBS) has announced a significant expansion of its fingerprint drug testing technology into the Australian waste management sector. Managed Waste Service (MWS), a leading provider in Australia, will implement the Intelligent Fingerprinting Drug Screening System across its operations i...
June 18, 2025Read the full article

Soligenix's SGX302 Shows Promise in Treating Psoriasis with Fewer Risks
Psoriasis, a chronic autoimmune disorder affecting over 7.5 million adults in the United States, presents not only physical discomfort but also significant emotional distress. Soligenix Inc. (NASDAQ: SNGX) is making strides in addressing this condition with its proprietary therapy, SGX302, which has shown promising results ...
June 18, 2025Read the full article

LezDo TechMed Introduces Innovative Billing System for Medical Record Reviews
LezDo TechMed, a leading U.S. medical record review outsourcing firm, has unveiled CaseDrive, a revolutionary billing system designed to transform the medical record review industry. This innovative platform offers real-time billing visibility and automated invoicing, targeting the core issues of hidden fees, confusing invo...
June 18, 2025Read the full article

HeartBeam Inc. Strengthens Cardiac Care Innovation with New Patents
HeartBeam Inc. (NASDAQ: BEAT) has recently been granted two new U.S. patents, further solidifying its intellectual property portfolio in the realm of remote cardiac diagnostics. These patents cover the company's innovative 3D ECG device and a rhythm analysis algorithm, both of which are pivotal in advancing cardiac care tec...
June 18, 2025Read the full article

HeartBeam Inc. Strengthens Cardiac Tech Portfolio with New Patents
HeartBeam Inc. (NASDAQ: BEAT) has recently been granted two new U.S. patents, enhancing its intellectual property portfolio and supporting its mission to revolutionize remote cardiac diagnostics. These patents cover the company's compact, cable-free 3D ECG device and a sophisticated rhythm analysis algorithm designed to det...
June 18, 2025Read the full article

Trump's Override of California EV Mandate Impacts Tesla and Startups
President Donald Trump has enacted a measure that nullifies California's electric vehicle (EV) mandate, a decision that undermines the state's ambitious plans to accelerate the reduction of greenhouse gas emissions from vehicles. This legislative action, following the GOP Senate's vote against California's 2035 EV mandate, ...
June 18, 2025Read the full article

California Approves World's Largest Battery Energy Storage Project
The California Energy Commission's approval of the Darden Clean Energy Project represents a pivotal moment in the state's ambitious clean energy agenda. As the largest battery energy storage system (BESS) in the world, this project underscores California's leadership in renewable energy and its commitment to combating clima...
June 18, 2025Read the full article

Platinum Group Metals Ltd. Advances Waterberg Project as Platinum Market Faces Third Year of Deficits
The platinum market is currently navigating through its third consecutive year of substantial supply deficits, with a recorded shortfall of approximately 992,000 ounces in 2024 and projections indicating a continued undersupply into 2025. This persistent gap between supply and demand has catalyzed a notable increase in plat...
June 18, 2025Read the full article

Nutriband Inc. Advances Aversa Fentanyl to Commercial Manufacturing Scale with Kindeva
Nutriband Inc. (NASDAQ: NTRB), in collaboration with Kindeva, has achieved a milestone in the development of Aversa Fentanyl by successfully scaling up its commercial manufacturing process. This development is pivotal as Aversa Fentanyl aims to be the world's first abuse-deterrent opioid patch, integrating Nutriband's AVERS...
June 18, 2025Read the full article

Mitesco's Robo-Agent A.I. Project Aims to Revolutionize Real Estate Sales Automation
Mitesco, Inc. has announced significant progress in its Robo-Agent software development project, targeting the residential real estate market with a beta test team comprising major industry players. This initiative comes at a critical time when agent compensation is decreasing and market activity remains stagnant, making pr...
June 18, 2025Read the full article

Red Cat Holdings Secures $46.75M in Registered Direct Offering to Fuel Drone Technology Expansion
Red Cat Holdings Inc. (NASDAQ: RCAT), a leader in drone technology, has successfully entered into securities purchase agreements with institutional investors for a registered direct offering. The company plans to sell 6,448,276 shares of common stock, aiming to raise approximately $46.75 million. This financial move is set ...
June 18, 2025Read the full article

